an international educational and networking forum for professionals in the field of apheresis medicine

HYATT REGENCY SAN FRANCISCO April 2-5, 2014

San FranciSco

aSFa &Waa Joint

Conference

corporate program

15th WAA Congress at the ASFA 2014 Annual Meeting

ASFA &WAA Joint

Conference

Corporate program

2 15th WAA Congress at the ASFA 2014 Annual Meeting • corporate program

CORPORATE SUPPORTERSASFA wishes to acknowledge the support of all of the companies and organizations who contributed generously to the 2014 ASFA & WAA Joint Conference.

Gold level Supporter

Keynote level Supporter

Bronze level SupporterS

SympoSia and FocuS Group SupporterS

award SupporterS

ASFA &WAA Joint

Conference

Corporate program

3san francisco, ca • Hyatt Regency San Francisco • April 2-5, 2014

PROGRAM

wedneSday, april 2, 2014

8:00AM – 11:00AM

Corporate Breakfast symposium (Pre-registration with Fenwal, A Fresenius Kabi Company Required)Supported by Fenwal, A Fresenius Kabi Company

Bayview A & B

9:45AM – 10:15AMapheresis review session Coffee BreakSupported by Fenwal, A Fresenius Kabi Company

Grand A

12:00PM – 3:00PMCorporate LunCh symposium (Pre-registration with Terumo BCT Required)Supported by Terumo BCT

Bayview A & B

3:30PM – 3:45PMapheresis review session Coffee BreakSupported by Fenwal, A Fresenius Kabi Company

Grand A

4:00PM – 6:00PMCorporate foCus Group (Pre-Registration with Alexion Pharmaceuticals Required)Supported by Alexion Pharmaceuticals

Regency B

6:00PM – 8:00PM

weLCome reCeption in exhiBit haLL Supported by Terumo BCTTerumo BCT is proud to sponsor the ASFA and WAA Joint Conference Welcome Reception in the conference exhibit hall. Please join us for cocktails, hors d’oeuvres, and to network with your colleagues. Visit the Terumo BCT booth and learn more about how we are advancing the delivery of therapeutic apheresis.

Terumo BCT is the world leader in blood component technologies and an innovator in the field of cell culture and cell therapy. TerumoBCT.com

Grand B & C

7:30PM – 10:30PMCorporate Dinner symposium (Pre-registration with Octapharma Required)Supported by Octapharma

Bayview A & B

ASFA &WAA Joint

Conference

Corporate program

4 15th WAA Congress at the ASFA 2014 Annual Meeting • corporate program

thurSday, april 3, 2014

7:00AM – 8:15AM Breakfast with the expert iSupported by Therakos

Bayview A & B

10:00AM – 10:45AM Coffee BreakSupported by Fenwal, A Fresenius Kabi Company

Grand B & C

3:30PM – 4:00PM Coffee BreakSupported by Fenwal, A Fresenius Kabi Company

Grand B & C

7:00PM – 10:00PM Corporate foCus Group (Pre-registration with Sanofi Oncology Required)Supported by Sanofi Oncology

Regency A

7:30PM – 10:30PMCorporate Dinner symposium (Pre-Registration with Alexion Pharmaceuticals Required)Supported by Alexion Pharmaceuticals

Bayview A & B

Friday, april 4, 2014

7:00AM – 8:30AM Breakfast with the expert iiSupported by Therakos

Bayview A & B

6:00PM – 9:00PMCorporate Dinner symposium (Pre-registration with Therakos required)Supported by Therakos

Bayview A & B

Saturday, april 5, 2014

7:00AM – 8:30AM Breakfast with the expert iiiSupported by Therakos

Bayview A & B

ASFA &WAA Joint

Conference

Corporate program

5san francisco, ca • Hyatt Regency San Francisco • April 2-5, 2014

EXHIBIT LIST AND FLOOR PLAN

exhiBitor liSt Booth #

3M Health Care Infection Prevention Division

AABB

Alexion Pharmaceuticals

American Society for Apheresis (ASFA)

Angiodynamics

Asahi Kasei Medical America, Inc.

Fenwal, A Fresenius Kabi Company

Fresenius Medical Care Apheresis Care Group

Healthcare - ID

Kaneka Pharma America, LLC

Octapharma

Sanofi Oncology

Terumo BCT

Therakos

UC San Diego

University of Virginia

World Apheresis Association (WAA)

exhiBit hourS

Exhibits are located in the Grand B & C

• Wednesday, April 2, 2014 6:00pm – 8:00pm• Thursday, April 3, 2014 10:00am – 8:00pm• Friday, April 4, 2014 7:00am – 10:45am

exhiBit Floor plan

ASFA &WAA Joint

Conference

Corporate program

6 15th WAA Congress at the ASFA 2014 Annual Meeting • corporate program

EXHIBITOR DIRECTORY3m health care - inFection prevention diviSion

Arizant Healthcare Inc., a 3M Company, pioneered the concept of forced-air patient warming with the introduction of Bair Hugger™ therapy in 1987. Today, our groundbreaking lineup of temperature management products includes the Bair Paws™ system and the Ranger™ fluid warming systems.

aaBB

AABB is an international healthcare association made up of over 10,000 individual and institutional members in the field of transfusion medicine and cellular therapies. Visit our booth to peruse our latest books in the area of apheresis, including Apheresis: Principals and Practices, 3rd edition, edited by Bruce C. McLeod, MD, Zbigniew M. Szczepiorkowski, MD, PhD, Robert Weinstein, MD, and Jeffrey L. Winters, MD. Ask us about our upcoming educational sessions, grant opportunities, and more. All ASFA attendees will receive the AABB member discounts on all books purchased at the meeting.

alexion pharmaceuticalS

Alexion Pharmaceuticals is a biopharmaceutical company focused on serving patients with severe and ultra-rare

disorders through the innovation, development and commercialization of life-transforming products. Alexion developed and markets Soliris® (eculizumab) as a treatment for patients with PNH and aHUS. Alexion is evaluating other potential indications for Soliris and is developing four other innovative product candidates.

american Society For aphereSiS (aSFa)

ASFA is an organization of physicians, scientists, and allied health professionals whose mission is to advance apheresis medicine for patients, donors and practitioners through education, evidence-based practice, research and advocacy. ASFA represents a broad range of professionals involved in: donor apheresis, apheresis in transplantation & therapeutic apheresis.

anGiodynamicS

AngioDynamics Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology. AngioDynamics’ diverse product lines include market-leading ablation systems, fluid management systems, vascular access products, angiographic products and accessories, angioplasty products, drainage products, thrombolytic products and venous products. More information is available at www.AngioDynamics.com.

ASFA &WAA Joint

Conference

Corporate program

7san francisco, ca • Hyatt Regency San Francisco • April 2-5, 2014

aSahi KaSei medical america inc.

Asahi Kasei Medical, a pioneer in blood purification, proudly introduces our Therapeutic Apheresis Division. This division provides innovative therapies for intractable diseases by extending the frontiers of medical devices and systems for extracorporeal treatment, such as plasmapheresis. In the dialysis market Asahi Kasei Medical offers REXEED™ series dialyzers. REXEED™, the high performance polysulfone dialyzer, offers unparalleled performance and patient safety, and is offered in multiple sizes including 2.5 square meters.

Fenwal, a FreSeniuS KaBi company

Fenwal, a Fresenius Kabi company, is a pioneer and global leader in the development of products that improve the safety and availability of blood. Fenwal products help shape the practice of transfusion medicine, making life-saving blood therapies available to the medical professionals and patients worldwide who rely on them.

FreSeniuS medical care aphereSiS ServiceS

Fresenius Medical Care’s Therapeutic Apheresis Program provides high quality patients care, while substantially reducing the cost of these

services to medical centers. We provide a fully equipped apheresis program to include state of the art equipment, specially trained registered nurses and Medical Director oversight. We provide: Plasmapheresis, Leukocytaphersis, Thrombocytapheresis, Erythrocyapheresis, LDL Apheresis, and Photopheresis. Treating: Thrombotic Thrombocytopenic Purpura (TTP), Sickle Cell Disease, Guillain-Barre Syndrom (GBS); Myasthenia Gravis; Autoimmune Polyneuropathies: Pulmonary Renal Syndrome; Systemic Lupus Erythematosus.

healthcare-id

Healthcare-ID’s Donor-ID Web™ automates documentation at fixed and mobile collection sites and interfaces to most BCDMS/BECS. Modules: Registration, Health History, CASI, Internet CASI, Physical Exam, Daily QC, Phlebotomy, Shipping, Survey, Donor Adverse Reaction (AABB biovigilence).

KaneKa pharma america, llc

Kaneka is the developer and manufacturer of the Liposorber System, which is an FDA approved LDL-Apheresis system that is used in hospitals, clinics, and physician offices across the US for the treatment of patients who cannot meet their LDL cholesterol goals despite maximum diet and drug therapy.

ASFA &WAA Joint

Conference

Corporate program

8 15th WAA Congress at the ASFA 2014 Annual Meeting • corporate program

octapharma

Company Description

SanoFi oncoloGy

Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets and animal health. Sanofi is listed in Paris (EURONEXT : SAN) and in New York (NYSE: SNY). Sanofi is the holding company of a consolidated group of subsidiaries and operates in the United States as Sanofi US, also referred to as Sanofi-aventus U.S. LLC. For more information on Sanofi US, please visit http://www.sanofi.us or call 1-800-981-2491

terumo Bct

In April, CaridianBCT and Terumo Transfusion united as Terumo BCT, the world leader in blood component technologies and an innovator in the field of cell culture and cell therapy. For more information visit, Booth 7 or TERUMOBCT.com.

theraKoS

Therakos, Inc is a worldwide leader in extracorporeal photopheresis. The THERAKOS™ CELLEX® and THERAKOS UVAR XTS® Photopheresis Systems are approved for the palliative treatment of skin manifestations of Cutaneous T-Cell Lymphoma that are unresponsive to other forms of treatment. For more information about Therakos and its products visit www.therakos.com.

uc San dieGo

Company Description

univerSity oF virGinia

The goal of the Office of Continuing Medical Education is to create opportunities for learning that will enhance and expand the skills and knowledge of health care professionals and improve the quality of health care delivery in Virginia, surrounding states, the nation and the world. Continuing medical education (CME) is part of the learning continuum initiated in undergraduate education, intensified during graduate medical education and maintained throughout the life of the health care professional. CME links this lifelong learning process to the research, teaching, patient care, and public service missions of the School of Medicine and the goals of the Virginia Generalist Initiative.

ASFA &WAA Joint

Conference

Corporate program

9san francisco, ca • Hyatt Regency San Francisco • April 2-5, 2014

world aphereSiS aSSociation (waa)

The World Apheresis Association is an umbrella organization for national and international professional societies devoted to the scientific, medical, practical, technical, administrative, and educational aspects of apheresis.

an international educational and networking forum for professionals in the field of apheresis medicine

aSFa &Waa Joint

Conference

ASFA HEAd OFFICE

201-375 wEST 5TH AvE

vANCOUvER, BRITISH COLUMBIA v5Y 1j6

P: 604.484.2851 • F: 604.874.4378

ASFA@APHERESIS.ORG